Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 1, 2000, Pages 225-231

  Hagiwara, Shin Ichi ^a   Ishii, Yoshiki ^a   Kitamura, Satoshi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BLEOMYCIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; ENDOTHELIUM CELL; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0033909952     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.1.9903129     Document Type: Article

References (44)

1. 1. Phan, S. M. 1989. Diffuse interstitial fibrosis. In D. Massaro, editor. Lung Cell Biology. Marcel Dekker, New York. 907-980.
2. 2. Fridovich, I. 1978. The biology of oxygen radicals. Science 201:875-880.
3. 3. Freeman, B. A., and J. D. Crapo. 1982. Biology of disease: free radicals and tissue injury. Lab. Invest. 47:412-426.
4. 4. Schraufstatter, I. U., and C. C. Cochrane. 1991. Oxidants; types, sources and mechanisms of injury. In R. G. Crystal and J. B. West, editors. The Lung: Scientific Foundations. Raven Press, New York. 1803-1810.
5. 5. Sausville, E. A., R. W. Stein, J. Peisach, and S. B. Horwitz. 1978. Properties and products of the degradation of DNA by bleomycin and iron(II). Biochemistry 17:2746-2754.
6. 6. Galvan, L., C. H. Huang, A. W. Prestayko, J. T. Stout, J. E. Evans, and S. T. Crooke. 1981. Inhibition of bleomycin-induced DNA breakage by superoxide dismutase. Cancer Res. 41:5103-5106.
7. 7. Cunningham, M. L., P. S. Ringrose, and B. R. Lokesh. 1984. Inhibition of the genotoxicity of bleomycin by superoxide dismutase. Mutat. Res. 135:199-202.
8. 8. Cantin, A. M., R. C. Hubbard, and R. G. Crystal. 1989. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139: 370-372.
9. 9. Borok, Z., R. Buhl, G. J. Grimes, A. D. Bokser, R. C. Hubbard, K. J. Holroyd, J. M. Roum, D. B. Czerski, A. M. Cantin, and R. G. Crystal. 1991. Glutathione aerosol therapy to suppress the burden of oxidants on the alveolar epithelial surface in idiopathic pulmonary fibrosis. Lancet 338:215-216.
10. 10. Gillissen, A., and D. Nowak. 1998. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir. Med. 92:609-623.
11. 11. Henry, J. H., L. Rui-ming, and T. Li. 1997. Glutathione cycling in oxidative stress. In L. B. Clerch and J. M. Donald, editors. Oxygen, Gene Expression, and Cellular Function. Marcel Dekker, New York. 99-121.
12. 12. Jamieson, D. D., D. R. Kerr, and I. Unsworth. 1987. Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice. Lung 165:239-247.
13. 13. Shahzeid, S., B. Sarnstrand, P. K. Jeffery, R. J. McAnulty, and G. J. Laurent. 1991. Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur. Respir. J. 4:845-852.
14. 14. Norbert, B. 1985. Inhibition of bleomycin lung toxicity by N-acetyl cysteine in the rat. Pathology 17:108-110.
15. 15. Behr, J., K. Maier, B. Degenkolb, F. Krombach, and C. Vogelmeier. 1997. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 156:1897-1901.
16. 16. Bridgeman, M. M. E., M. Marsden, C. Selby, D. Morrison, and W. Macnee. 1994. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 49:670-675.
17. 17. Cotgreave, I. A., A. Eklund, K. Larsson, and P. W. Moldeus. 1987. No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid. Eur. J. Respir. Dis. 70:73-77.
18. 18. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41: 467-470.
19. 19. Woessner, J. F. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem Biophys. 93:440-447.
20. 20. The BAL Cooperative Group Steering Committee. 1990. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison group. Am. Rev. Respir. Dis. 141:188.
21. 21. Waters, L. C., M. I. Schwartz, R. M. Cherniak, J. A. Waldron, T. L. Dunn, R. E. Stanford, and T. E. King. 1987. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships and lung histopathology and clinical response to therapy. Am. Rev. Respir. Dis. 135:696.
22. 22. Cailes, J. B., C. O'Connor, P. Pantelidis, A. M. Southcott, M. X. Fitzgerald, C. M. Black, and R. M. du Bois. 1996. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis. Eur. Respir. J. 9:992-999.
23. 23. Obayashi, Y., I. Yamadori, J. Fujita, T. Yoshinouchi, N. Ueda, and J. Takahara. 1997. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 112:1338-1343.
24. 24. Davis, G. S., A. R. Brody, and J. E. Craighead. 1978. Analysis of airspace and interstitial lung disease. Am. Rev. Respir. Dis. 118:7-15.
25. 25. Kumar, R. K. 1989. Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica. Am. J. Pathol. 135:605-614.
26. 26. Antoniades, H. N., J. Neville-Golden, T. Galanopoulos, R. L. Kradin, A. J. Valente, and D. T. Graves. 1992. Expression of monocyte chemoattractant protein-1 mRNA in human idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. U.S.A. 89:5371-5375.
27. 27. Standiford, T. J., M. W. Rolfe, S. L. Kunkel, J. P. Lynch, III, M. D. Burdick, A. R. Gilbert, M. B. Orringer, R. I. Whyte, and R. M. Strieter. 1993. Macrophage inflammatory protein-1a expression in interstitial lung disease. J. Immunol. 151:2852-2863.
28. 28. Standiford, T. J., M. R. Rolfe, S. L. Kunkel, J. P. Lynch, III, F. S. Becker, M. B. Orringer, S. Phan, and R. M. Strieter. 1993. Altered production and regulation of monocyte chemoattractant protein-1 from pulmonary fibroblasts isolated from patients with idiopathic pulmonary fibrosis. Chest 103:121S.
29. 29. Strieter, R. M., and S. L. Kunkel. 1997. Chemokines. In R. G. Crystal and J. B. West, editors. The Lung, 2nd ed. Lippincott-Raven Publishers, Philadelphia. 155-186.
30. 30. Walzt, A., S. L. Kunkel, and R. M. Strieter. 1996. C-X-C chemokines: an overview. In A. E. Koch and R. M. Strieter, editors. Chemokines in Disease. R. G. Landes Co., Austin, TX. 1-26.
31. 31. Taub, D. D. 1996. C-C chemokines: an overview. In A. E. Koch and R. M. Strieter, editors. Chemokines in Disease. R. G. Landes Co., Austin, TX. 27-54.
32. 32. Keane, M. P., T. J. Standiford, and R. M. Strieter. 1997. Chemokines are important cytokines in the pathogenesis of interstitial lung disease. Eur. Respir. J. 10:1199-1202.
33. 33. Blackwell, T. S., and J. W. Christman. 1997. The role of nuclear-κB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17:3-9.
34. 34. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247-2258.
35. 35. Tozawa, K., S. Sakurada, K. Kohri, and T. Okamoto. 1995. Effects of anti-nuclear factor κB reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res. 55:4162-4167.
36. 36. Shen, A. S., C. Haslett, D. C. Feldsin, P. M. Henson, and R. M. Cherniack. 1988. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am. Rev. Respir. Dis. 137:564-571.
37. 37. Thrush, M. A., E. G. Mimnaugh, E. Ginsburgh, and T. E. Gram. 1982. Studies on the interaction of bleomycin A with rat lung microsome II: involvement of adventitious iron and reactive oxygen in bleomycin-mediated DNA chain breakage. J. Pharmacol. Exp. Ther. 221:159-165.
38. 2 on peroxidation of arachidonic acid. Am. Rev. Respir. Dis. 127(Suppl.):S287.
39. 39. Aruoma, O. I., B. Halliwell, B. M. Hoey, and J. Butler. 1989. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 6:593-597.
40. 40. Forman, H. J., and D. C. Skelton. 1990. Protection of alveolar macrophages from hyperoxia by r-glutamyl transpeptidase. Am. J. Physiol. 259:L102-107.
41. 41. Cantin, A. M., P. Larivee, and R. O. Begin. 1990. Extracellular glutathione suppress human lung fibroblast proliferation. Am. J. Respir. Cell Mol. Biol. 3:79-85.
42. 42. Gharaee-Kermani, M., E. M. Denholm, and S. H. Phan. 1996. Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J. Biol. Chem. 271:17779-17784.
43. 43. Buhl, R., C. Vogelmeier, M. Critenden, R. C. Hubbard, R. F. Hoyt R, E. M. Wilson, A. M. Cantin, and R. G. Crystal. 1990. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc. Natl. Acad. Sci. U.S.A. 87:4063-4067.
44. 44. Webb, W. R. 1962. Clinical evaluation of a new effective mycolytic agent (N-acetyl-L-cysteine). Am. Rev. Respir. Dis. 86:115-116.